Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Newer

gregque

08/08/14 5:56 PM

Post #14

sporty norty what is a member mark explain please

gregque

08/08/14 5:45 PM

Post #13

up 1.17 with a price target @ 20 we are on the way buy more people we will see good times very quickly

gregque

08/08/14 5:39 PM

Post #12

21 million + shares owned by institutions

gregque

08/08/14 5:38 PM

Post #11

will be buying more b 4 phase3 results all i can get

gregque

08/08/14 5:37 PM

Post #10

this will be huge in 2016

gregque

08/08/14 5:36 PM

Post #9

nice upside

Blutribe

06/18/14 10:51 AM

Post #8

Radius Health Announces Oral Presentations at the International Society of Endocrinology and the Endocrine Society

CAMBRIDGE, Mass., June 18, 2014 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq:RDUS), will present scientific data from studies conducted with abaloparatide (BA058) at the joint meeting of the International Society of Endocrinology and the Endocrine Society (ICE/ENDO 2014) in Chicago, Illinois, June 21-24, 2014.

Abstracts related to Radius Health include:

Title: A Transdermal Patch Delivering the PTHrP1-34 Analog, Abaloparatide (BA058), Dose-Dependently Increases Spine and Hip BMD Compared to Placebo
Abstract #: OR22-4
Presenter: Alan G. Harris, MD, PhD, FRCP
Presentation date/time: Sunday June 22, 12:15pm.
Session: OR22-Osteoporosis-Clinical Trials Clinical
Room/Details: W181 (McCormick Place West Building)

Blutribe

06/17/14 10:46 AM

Post #7

2 large inside buys in past few days..over 1m shares..news expected???

Insider Buying: Radius Health Director Buys 587,500 Shares of Stock (RDUS)
Posted by Zach Kirkland on Jun 17th, 2014 //

Radius Health (NASDAQ:RDUS) major shareholder Growth N. V. Biotech acquired 1,000,000 shares of the company’s stock in a transaction that occurred on Friday, June 6th. The shares were purchased at an average price of $8.00 per share, for a total transaction of $8,000,000.00